Key result
Heart failure with preserved ejection fraction is a common clinical syndrome in hemodialysis patients that requires specific diagnostic criteria and preventive measures.
Answers are grounded in this paper and cite their sources.
This review highlights the clinical manifestations, diagnosis, and management of heart failure with preserved ejection fraction in patients undergoing hemodialysis.
Cardiovascular diseases are the most common (50-60%) cause of death in patients with chronic renal failure, especially in its final stage (ESRD). Symptomatic left ventricular dysfunction with preserved ejection fraction is defined as a clinical syndrome of diastolic heart failure. This is clinically manifested by dyspnea, reduced tolerance to physical effort and the rapid changes in the volume of circulating fluid. ‘‘Unexpected’’ development of acute pulmonary edema is often the most difficult clinical manifestation. Diagnosis is based on the dialysis population adjusted criteria (NYHA-R) which are supported by the parameters of standard echocardiography and tissue Doppler imaging of the left ventricle and left atrium. Preventive measures and conventional drug therapy for controlling anemia, secondary hyperparathyroidism, ischemic heart disease and other contributing factors including the proper selection of available dialysis procedure are essential for prevention and treatment.
No takes yet. Share an insight, caveat, or question.
Poskurica et al. (2017) conducted a review in Heart failure with preserved left ventricular ejection fraction in hemodialysis patients. Heart failure with preserved ejection fraction is a common clinical syndrome in hemodialysis patients that requires specific diagnostic criteria and preventive measures.
Synapse has enriched 10 related papers. Consider them for comparative context: